Vendor needs to provide transcranial magnetic stimulation system for use in a clinical setting. The system will support evidence–based, non–invasive neuromodulation treatments for Veterans diagnosed with major depressive disorder, obsessive–compulsive disorder (OCD), anxiety disorders, and substance use disorders, including smoking addiction/smoking cessation. The Government seeks information on commercially available TMS solutions, including associated accessories, software, and support services, to determine capabilities, availability, and potential acquisition strategies for a future procurement. The vendors must demonstrate the ability to meet all requirements for this notice.